But no journal would accept a paper that says our drug is entering clinical trials
-
-
-
It should. If you show how you designed it. Otherwise, how do we know it is AI and not sheer luck?
Kraj razgovora
Novi razgovor -
-
-
No change of the old, continuously failing paradigm 1disease 1target 1molecule
#drugdiscovery dogma for complex disease better syndromes that are poorly understood. At best this is exponentially failing faster, cheaper but NO progress towards#Precisionmedicine#pharma#biotechHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.